Association between inflammation and insulin resistance in U.S. nondiabetic adults: Results from the Third National Health and Nutrition Examination Survey

Diabetes Care

Volumn 27, Issue 12, 2004, Pages 2960-2965

  Chen, Jing ^a,b   Wildman, Rachel P ^b   Hamm, L Lee ^b   Muntner, Paul ^a,b   Reynolds, Kristi ^a   Whelton, Paul K ^a,b   He, Jiang ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; FIBRINOGEN; GLUCOSE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; BODY MASS; CALCULATION; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE MARKER; EDUCATION; FEMALE; HEALTH SURVEY; HOMEOSTASIS; HUMAN; IMMOBILIZATION; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; RACE; REVIEW; SEX; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADULT; BIOLOGICAL MARKERS; ETHNIC GROUPS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIFE STYLE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES;

EID: 9444246403     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.12.2960     Document Type: Review

References (33)

1. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus. Lancet 340:925-929, 1992
2. Ginsberg HN: Insulin resistance and cardiovascular disease. J Clin Inves 106:453-458, 2000
3. Chen J, Muntner P, Hamm L, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in non-diabetic US Adults. J Am Soci Nephrol 14:467-477, 2003
4. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486, 1995
5. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998
6. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
7. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P: Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106:2908-2912, 2002
8. Festa A, Hanley AJ, Tracy RP, D'Agostino R, Haffner SM: Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108:1822-1830, 2003
9. Ford ES: The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Suvey. Atherosclerosis 168:351-358, 2003
10. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA: High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455-461, 2002
11. Jeppesen JL, Maheux P, Facchini FS: White blood cell count and insulin resistance in healthy nonsmoking men. Am Heart J 127:459-461, 1994
12. Sinagra D, Greco D, Scarpitta AM, Bonaventura V: Serum uric acid, insulin secretion and resistance in nonhyperuricemic and hyperuricemic obese female subjects. Int J Obes 20:1041-1043, 1996
13. Vuorinen-Markkola H, Yki-Jarvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29, 1994
14. Facchini F, Chen YD, Hollenbeck CB, Reaven GM: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
15. Imperatore G, Riccardi G, Iovine C, Rivellese A, Vaccaro O: Plasma fibrinogen: a new factor of the metabolic syndrome. Diabetes Care 21:649-654, 1998
16. Mennen LI, Balkau B, Charles MA, D'Hours A, Mauff JI, the DESIR Study Group: Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. Thromb Heamost 82:1106-1111, 1999
17. Fernandez-Real J, Ricart-Engel W, Arroyo E, Rafael B, Casamitiana-Abella R, Cabrero D, Fernandez-Castaner M, Soler J: Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21:62-68, 1998
18. Sheu WHH, Chen YT, Lee WJ, Wang CW, Lin LY: A relationship between serum ferritin and insulin resistance syndrome is present in nondiabetics women but not in non-diabetic men. Clin Endocrinol 58:380-385, 2003
19. National Center for Health Statistics: Plan and operation of the Third National Health and Nutrition Examination Survey 1988-94. Vital Health Stat 32:1-407, 1994
20. National Center for Health Statistics: The Third National Health and Nutrition Examination Survey (NHANES III 1988-94): Reference Manuals and Reports [CD-ROM]. Hyattsville, MD, National Center for Health Statistics, 1996
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412-419, 1985
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
23. National Kidney Foundation Kidney Disease Outcome Quality Initiative (K/ DOQI) Advisory Board: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39:S32-S33, 2002
24. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE: Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693-700, 2004
25. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397, 2004
26. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843, 2000
27. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397, 2003
28. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G: C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 25:1416-1420, 2001
29. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600, 2002
30. Devaraj S, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human, aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107:398-404, 2003
31. Clausen JO, Borch-Johnsen K, Ibsen H, Pedersen O: Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young health Caucasians. Euro J Endocrionol 138:63-69, 1998
32. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L: Detection of insulin resistance by simple qualitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87:144-147, 2002
33. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000